Latest news

Optics11 and Optics11 Life secure funding to accelerate growth

Optics11 and Optics11 Life have secured funding from Rabobank. The funding will be used to strongly accelerate growth across global markets, to further build the team for the future and to strategically expand the high-tech product portfolios of both business units. “This is the right moment to pick up the pace. Rabobank’s funding helps us […]

News

Amsterdam Venture Studios launches yearly startup book

The first edition of the Amsterdam Venture Studios startup book will bed dedicated to Amsterdam based startup founders connected to the academic knowledge institutes. We are proud of all this talent, who play such an important role in creating much-needed solutions. The startup book can help  forge connections between founders, potential employees, corporate or government […]

News

Gymstory moves into Amsterdam Venture Studios @ VUcampus

We are always over the moon when a startup moves through our ecosystem. Graduated from ACE Incubator, sport tech startup Gymstory moves into our VU Campus location.

News

Scientists at VU Amsterdam launch spin-off Incircular

Incircular BV was founded by three (bio)chemists at VU Amsterdam who have developed a novel technology for stabilizing proteins: INCYPRO. In their recently launched spin-off, Saskia Neubacher, Sven Hennig and Tom Grossmann will use this technology to stabilize proteins for applications in drug development, diagnostic testing, and biocatalysis. INCYPRO-stabilized proteins Proteins are a class of […]

News

Law Hub launches start-up fund

Law Hub offers entrepreneurs investments of €2.500 to develop an innovative justice product or start-up idea.

News

LUMICKS and LAVA Therapeutics enter collaboration to characterize its tumor-specific γδ T-cell engagers

In their quest of creating safe and effective immunotherapy cancer treatments, VU spinoff LUMICKS and Amsterdam UMC spinoff LAVA Therapeutics joined forces. The partnership aims to evaluate the efficacy of various tumor-specific γδ T-cell engagers based on the resulting binding strengths (cell avidity) between T cells and tumors, measured with LUMICKS newly installed z-Movi® Cell […]

News

PacingCure wins the Venture Challenge 2020

Amsterdam UMC spin-off PacingCure is the winner of the Venture Challenge at the online edition of the Dutch Life Science Conference on the 26th of November. PacingCure develops precision gene therapies for common cardiac arrhythmias and cardiomyopathies, aiming to restore the natural pacing of the heart. The company is founded on combined research from the […]

News

Startup Digi.bio one of the Top 10 most groundbreaking academic startups in NL

The ten winners of the prestigious Academic Startup Competition 2020 can use the title ‘Best Academic Startup of 2020’ for the coming year. The winning startups were chosen by an expert jury after a thrilling final in which all 20 finalists were asked to pitch. The ten winners were chosen on the basis of their value proposition, the […]

News

Mona Keijzer officially launched ACE initiative MKB Digital Workspace

On Friday November 20 State Secretary Mona Keijzer launched the national SME workshops digitization. The State Secretary for Economic Affairs and Climate talked to SME entrepreneurs and students. During the online event, Mona Keijzer launched the SME workshops by offering them to MKB Nederland. The majority of SME entrepreneurs are aware of the opportunities and […]

News

LUMICKS and Leucid Bio enter into a strategic collaboration

LUMICKS, a spin-off of Vrije Universiteit Amsterdam, is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen […]

News